Anthony J. Cannon, MD, FACE
Departments
Cooper University Health Care Titles
- Endocrinologist
Board Certifications
- American Board of Internal Medicine (Internal Medicine)
- American Board of Internal Medicine (Endocrinology, Diabetes, and Metabolism)
Professional Type
Cooper Care Alliance
NPI
1831259340
Office Locations
Cooper Care Alliance at Brace Road
1210 Brace Road
Cherry Hill
, NJ 08034
Phone: 856.536.1515
Maps
& Directions
Education & Training
| Medical School | Cornell University, New York, NY |
|---|---|
| Internship | Internal Medicine - Hartford Hospital, Hartford, CT |
| Residency | Internal Medicine - Baystate Medical Center, Springfield, MA |
| Fellowship | Endocrinology, Temple University Hospital, Philadelphia, PA |
Memberships
- American Diabetes Association
- National Medical Association
- Thyroid Club of South Jersey
- American Association of Clinical Endocrinologists (AACE)
Awards and Honors
- Recipient, American Diabetes Association Chair’s Citation Award - 2015
- Fellow, American College of Endocrinology, FACE - 2012
Publications
Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S5-S13. doi: 10.18553/jmcp.2018.24.9-a.s5. PMID: 30156443.
Handelsman Y, Wyne K, Cannon A, Shannon M, Schneider D. Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S14-S29. doi: 10.18553/jmcp.2018.24.9-a.s14. Erratum in: J Manag Care Spec Pharm. 2018 Nov;24(11):1196a. PMID: 30156445.
Heile M, Wyne K, Billings LK, Cannon A, Handelsman Y, Shannon M. Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S42-S52. doi: 10.18553/jmcp.2018.24.9-a.s42. PMID: 30156446.
Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S5-S13. doi: 10.18553/jmcp.2018.24.9-a.s5. PMID: 30156443.
Shomali ME, Ørsted DD, Cannon AJ. Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials. Diabet Med. 2017 Feb;34(2):197-203. doi: 10.1111/dme.13185. Epub 2016 Aug 16. PMID: 27412701; PMCID: PMC5248619.
Ard J, Cannon A, Lewis CE, Lofton H, Vang Skjøth T, Stevenin B, Pi-Sunyer X. Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials. Diabetes Obes Metab. 2016 Apr;18(4):430-5. doi: 10.1111/dom.12632. Epub 2016 Feb 11. PMID: 26744025; PMCID: PMC6084344.
Peyrot M, Egede LE, Campos C, Cannon AJ, Funnell MM, Hsu WC, Ruggiero L, Siminerio LM, Stuckey HL. Ethnic differences in psychological outcomes among people with diabetes: USA results from the second Diabetes Attitudes, Wishes, and Needs (DAWN2) study. Curr Med Res Opin. 2014 Nov;30(11):2241-54. doi: 10.1185/03007995.2014.947023. Epub 2014 Aug 18. PMID: 25079662.
Mehta JM, Miller JL, Cannon AJ, Mardekian SK, Kenyon LC, Jabbour SA. Ovarian leydig cell hyperplasia: an unusual case of virilization in a postmenopausal woman. Case Rep Endocrinol. 2014;2014:762745. doi: 10.1155/2014/762745. Epub 2014 Jun 19. PMID: 25045549; PMCID: PMC4089940.
Cannon AJ. Delivering culturally competent care in clinical practice: a call to action. J Natl Med Assoc. 2012 Jan-Feb;104(1-2):104-7. doi: 10.1016/s0027-9684(15)33514-8. PMID: 22708254.